The American Academy of Pediatrics’ (AAP) updated blood pressure guidelines classify more kids in higher BP categories and can more accurately predict which children are prone to heart disease later in life, an extensive analysis of the Bogalusa Heart Study has found.

Torrent Pharmaceuticals Limited has expanded its recent recall of blood pressure-regulating losartan tablets to include an additional 104 lots of the drugs, the company announced April 18.

Two studies published April 18 in the journal Cell have shined new light on the role genetics can play in developing obesity—or protecting against it.

The popular diabetes drug metformin reversed left ventricular hypertrophy (LVH) in a randomized trial of patients with coronary artery disease but without diabetes, suggesting a potential new use for the medication.

The FDA has cleared Gelesis100 hydrogel capsules to be used as a weight management aid alongside diet and exercise in adults with body mass indexes (BMIs) ranging from 25 to 40, according to an April 14 press release from the product’s manufacturer.

People diagnosed with type 2 diabetes at 40 or younger were about twice as likely to die over 5.6 years of follow-up compared to age-matched controls, according to a registry study from Sweden. But the relationship weakened substantially as the age of onset progressed, such that patients diagnosed in their 80s carried no excess mortality risk.

Medtronic has struck a value-based agreement with Blue Cross and Blue Shield of Minnesota in which the medical device company will pay back the insurer if patients using the Guardian Connect continuous glucose monitoring (CGM) system fail to keep their blood sugar levels within a specified range.

Rare protein-truncating variants in the apolipoprotein B (APOB) gene are linked to lower triglycerides and LDL cholesterol levels and also appear to be protective against coronary heart disease (CHD), according to a study published in Circulation: Genomic and Precision Medicine.